slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
7.680
KRW
|
-0,13%
|
|
+5,49%
|
-22,42%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.485.081
|
3.069.933
|
1.459.198
|
470.211
|
410.353
|
Bedrijfswaarde
1 |
1.441.942
|
3.090.374
|
1.483.621
|
532.352
|
413.298
|
K/w-verhouding
|
-80,7
x
|
142
x
|
-30,2
x
|
-8,34
x
|
-5,99
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
131
x
|
166
x
|
39,6
x
|
29,1
x
|
92,7
x
|
Bedrijfswaarde/omzet
|
128
x
|
167
x
|
40,3
x
|
33
x
|
93,4
x
|
Bedrijfswaarde/EBITDA
|
-34,3
x
|
-85,3
x
|
-93,9
x
|
-18,5
x
|
-11,2
x
|
Bedrijfswaarde/FCF
|
-
|
-102.001.939
x
|
-30.763.335
x
|
-5.500.948
x
|
-13.646.659
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
5
x
|
5,73
x
|
2,84
x
|
1,72
x
|
1,38
x
|
Aantal aandelen (in duizenden)
|
30.890
|
32.107
|
32.538
|
32.688
|
41.450
|
Referentieprijs
2 |
48.077
|
95.615
|
44.846
|
14.385
|
9.900
|
Datum van publicatie
|
12/03/21
|
12/03/21
|
17/03/22
|
20/03/23
|
13/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
11.303
|
18.543
|
36.828
|
16.139
|
4.427
|
EBITDA
1 |
-42.070
|
-36.231
|
-15.801
|
-28.808
|
-36.897
|
Bedrijfsresultaat (EBIT)
1 |
-44.573
|
-39.151
|
-19.099
|
-33.680
|
-41.928
|
Operationele Marge
|
-394,35%
|
-211,13%
|
-51,86%
|
-208,69%
|
-947,19%
|
Resultaat voor belastingen (EBT)
1 |
-16.509
|
27.536
|
-48.876
|
-56.831
|
-66.860
|
Nettowinst (verlies)
1 |
-16.509
|
27.570
|
-48.042
|
-55.974
|
-66.874
|
Nettomarge
|
-146,06%
|
148,68%
|
-130,45%
|
-346,82%
|
-1.510,71%
|
WPA
2 |
-595,4
|
671,5
|
-1.483
|
-1.724
|
-1.652
|
Free Cash Flow
|
-
|
-30.297
|
-48.227
|
-96.775
|
-30.286
|
FCF-marge
|
-
|
-163,38%
|
-130,95%
|
-599,63%
|
-684,17%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/03/21
|
12/03/21
|
17/03/22
|
20/03/23
|
13/03/24
|
Fiscaal tijdperk: december |
2023 Q3
|
---|
Omzet
1 |
0,357
|
EBITDA
|
-
|
Bedrijfsresultaat (EBIT)
|
-
|
Operationele Marge
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
Nettowinst (verlies)
|
-
|
Nettomarge
|
-
|
WPA
|
-
|
Dividend per aandeel
|
-
|
Datum van publicatie
|
15/11/23
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
20.441
|
24.423
|
62.141
|
2.945
|
Nettokaspositie
1 |
43.139
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-0,5642
x
|
-1,546
x
|
-2,157
x
|
-0,0798
x
|
Free Cash Flow
|
-
|
-30.297
|
-48.227
|
-96.775
|
-30.286
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
6,61%
|
-9,26%
|
-14,3%
|
-23,3%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-5,12%
|
-1,94%
|
-4,1%
|
-6,85%
|
Totale activa
1 |
-
|
-538.051
|
2.482.781
|
1.363.655
|
976.584
|
Nettoactief per aandeel
2 |
9.612
|
16.682
|
15.795
|
8.341
|
7.156
|
Cashflow per aandeel
2 |
617,0
|
162,0
|
854,0
|
549,0
|
146,0
|
Capex
1 |
3.962
|
22.208
|
56.433
|
31.747
|
7.273
|
Capex/omzet
|
35,05%
|
119,76%
|
153,23%
|
196,71%
|
164,3%
|
Datum van publicatie
|
12/03/21
|
12/03/21
|
17/03/22
|
20/03/23
|
13/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -22,42% | 235 mln. | | -1,43% | 104 mld. | | +8,96% | 105 mld. | | +4,40% | 22,94 mld. | | -12,15% | 22,34 mld. | | -4,36% | 19,25 mld. | | -39,98% | 17,08 mld. | | -10,04% | 16,96 mld. | | +6,79% | 14,16 mld. | | +38,61% | 12,63 mld. |
Biotherapeutische geneesmiddelen
|